U.S. Mortgage REITs Stock News

Universal Display (OLED) has drawn investor attention after reporting Q2 2026 earnings that showed lower revenue and net income year on year, while reiterating full year guidance and maintaining its cash dividend. See our latest analysis for Universal Display. The mixed Q2 report appears to sit against a backdrop of weaker recent trading for Universal Display, with the share price at US$80.36, the year-to-date share price return down 34.05%, and the 1-year total shareholder return down...

Morgan Stanley Investment Management recently launched two new Ethereum (MSSE) and Solana (MSOL) exchange-traded products on NYSE Arca that pass staking rewards directly to investors, while the firm also issued US$50.00 million of 4.500% senior unsecured notes due September 28, 2027, and expanded its leadership by hiring Emma Taylor to co-lead global internet banking. This move positions Morgan Stanley among the first major U.S. banks to package yield-bearing crypto exposure into regulated,...

Amgen recently announced that its Board of Directors declared a US$2.52 per share dividend for the third quarter of 2026, payable on September 11, 2026 to shareholders of record as of August 21, 2026. Separately, the European Medicines Agency’s CHMP issued a positive opinion on expanding Repatha’s use to high‑risk adults without prior heart attack or stroke, potentially broadening its clinical role in cardiovascular prevention. We’ll now explore how the CHMP’s positive opinion on expanding...

In late July 2026, Pfizer reported positive Phase 3 results for its oral JAK3/TEC inhibitor LITFULO in nonsegmental vitiligo and secured European Commission approval for its 2026–2027 XFG‑adapted COVID-19 vaccine for individuals six months and older. Together, these milestones highlight Pfizer’s push to build a broader immunology and dermatology franchise while maintaining a recurring role in seasonal COVID-19 vaccination campaigns. With this backdrop, we’ll now examine how LITFULO’s Phase 3...

Arista Networks stock has delivered a very strong multi year return, yet the latest valuation checks suggest the shares no longer stand out as a clear bargain. The intrinsic value estimate from a Discounted Cash Flow (DCF) model sits close to the current price, while market multiples lean rich. Arista Networks has returned about 6x over the past five years, which sets a high bar for any further upside to be justified by fundamentals. The launch of Arista's AI driven Zero Trust Branch...

Relay Therapeutics, a clinical-stage precision medicine company, recently announced it will report its second quarter 2026 results and corporate highlights on 6 August 2026, with investors watching closely for updates on its lead asset zovegalisib and other pipeline programs. Analysts have turned more optimistic ahead of this report, pointing to the potential for an earnings beat alongside progress in the company’s oncology and genetic disease trials as key areas of focus. With attention...

Euronet Worldwide, Inc. has reported past second-quarter 2026 results, with sales rising to US$1,108.4 million from US$1,074.3 million a year earlier, while net income fell to US$77.4 million from US$97.6 million and diluted EPS from continuing operations declined to US$1.71 from US$2.27. The combination of higher revenue but weaker profitability highlights that cost pressures or business mix shifts are affecting how effectively Euronet converts sales into earnings. We’ll now explore how...

Bitdeer Technologies Group (BTDR) drew fresh attention after releasing unaudited operating results for June 2026, highlighting sharp year over year gains in total hash rate, mining rigs under management, and self mined Bitcoin. See our latest analysis for Bitdeer Technologies Group. The June operating update landed alongside a sharp 24.72% 1 day share price return to US$11.10. However, the 30 day share price return is down 30.06% and the 1 year total shareholder return is down 13.89%, which...

Allegion earnings and buyback put fresh focus on the stock Allegion (NYSE:ALLE) is back in focus after reporting second quarter 2026 results that showed higher sales and net income versus a year earlier, along with the completion of a multi year share repurchase program. See our latest analysis for Allegion. At a share price of $157.06, Allegion has seen a 30 day share price return of 11.79% and a 90 day share price return of 15.92%. Over a 1 year period the total shareholder return is down...

China’s latest manufacturing data has sent a clear signal. The official PMI slipped to 49.2 in July, which points to weaker factory activity, softer exports to the U.S., and pressure on retail sales and jobs. At the same time, Chinese policymakers are talking up extra fiscal support and pro growth measures. For U.S. investors, this mix of softer demand abroad and potential policy support at home and overseas can change how industrial and manufacturing stocks are priced. This article looks at...

Southern Michigan Bancorp stock sat at $31.88 coming into the Q2 release, with a flat month behind it and a solid 90 day climb, and the results now force investors to decide whether the calm was complacency. The headline is simple. Earnings stayed firm with basic earnings per share at $0.66 and trailing 12 month earnings quality described as high, while the net profit margin eased to 21.3%. The question now is whether today’s price reaction reflects that mild squeeze in profitability or...

In late July 2026, analysts highlighted that Wall Street expected Avient to post year-over-year increases in earnings and revenue for the June 2026 quarter, with its Zacks Rank #2 and positive Earnings ESP suggesting a possible earnings beat ahead of results scheduled for August 6. This earnings optimism has drawn investor attention because it aligns with the company’s shift toward higher-value specialty materials, where even modest outperformance can materially influence how the market...

NCR Atleos (NATL) is back in focus after Credit Union 1 agreed to brand ATMs across 24 Circle K stores in Alaska, extending Atleos’ presence in both busy and remote locations. See our latest analysis for NCR Atleos. Against this new Credit Union 1 agreement, NCR Atleos shares closed at US$46.89, with a 30 day share price return of 8.02% and a year to date share price return of 25.95%, while the 1 year total shareholder return stands at 53.24%, suggesting momentum has been building recently...

Evercore stock added 2.7% today, a firm move higher after earnings for a company that had drifted lower over the past month. The market is cheering what looks like one simple story. Advisory and underwriting fees produced a record second quarter, and the first half of 2026 landed as a record on adjusted earnings per share. The real story is more nuanced. The market is paying up for an investment bank that just posted roughly US$1.0b in adjusted net revenue for the quarter and a 22.7% adjusted...

Knight-Swift Transportation Holdings Inc. has released its second-quarter 2026 results, reporting sales of US$1,764.39 million, revenue of US$2,095.71 million, and net income of US$43.19 million, all higher than the same period in 2025. Over the first half of 2026, however, net income fell to US$41.87 million despite higher revenue, highlighting a contrast between improving quarterly performance and more pressured year-to-date profitability. We’ll now examine how the stronger second-quarter...

Bright Horizons Family Solutions Inc. has now reported its second-quarter 2026 results, with sales rising to US$779.18 million from US$731.57 million a year earlier, while net income eased to US$40.64 million from US$54.78 million and diluted EPS from continuing operations slipped to US$0.79 from US$0.95. Despite the year-on-year profit decline, the company exceeded analyst expectations on both revenue and non-GAAP earnings, reaffirmed full-year revenue guidance around US$3.10 billion, and...

Legend Biotech (LEGN) is back in focus after CEO and board member Ying Huang, Ph.D., resigned on July 24, 2026. CARVYKTI business head Alan Bash is stepping in as Interim CEO. See our latest analysis for Legend Biotech. Legend Biotech's share price has come under pressure despite its cell therapy focus, with the 30 day share price return down 34.04% and the 1 year total shareholder return down 51.24%, suggesting momentum has faded as investors reassess execution risk after the CEO change. If...

In July 2026, Graco Inc. reported past second-quarter sales of US$590.55 million and net income of US$144.93 million, with both basic and diluted earnings per share from continuing operations rising year on year, alongside higher sales and earnings for the first half of the year. Graco also completed a long-running share repurchase program launched in 2018, buying back nearly 5 million shares for US$393.29 million, which reduces the share count and can make each remaining share’s claim on...

Quanta Services (PWR) has drawn fresh attention after reporting second quarter 2026 earnings along with a higher full year outlook, with both sales and net income figures materially above the prior year period. See our latest analysis for Quanta Services. The earnings release and higher full year guidance arrived alongside a sharp move in Quanta Services' share price, with a 1 day share price return of 17.26% and a year to date share price return of 49.65%. The 1 year total shareholder return...

Conagra Brands (CAG) is back in focus after announcing a management reshuffle that includes the retirement of long-serving Chief Operating Officer Tom McGough and the elimination of the COO role. See our latest analysis for Conagra Brands. The executive reshuffle lands at a time when Conagra Brands’ recent momentum has improved, with a 30 day share price return of 11.66% and a 90 day share price return of 6.90%. However, longer term total shareholder returns over one, three and five years...

GE Vernova (GEV) has drawn fresh attention after raising its full year outlook for revenue and free cash flow, pointing to strong orders and growing power needs from AI focused data centers. See our latest analysis for GE Vernova. The latest outlook upgrade and strong second quarter earnings come after a sharp move in GE Vernova’s share price. The stock has a year to date share price return of 44.5% and a 1 year total shareholder return of 49.06%. However, recent 30 day and 90 day share price...

GATX Corporation recently reported past second-quarter 2026 results, with revenue rising to US$580.1 million and net income to US$103.4 million, and raised its full-year 2026 earnings guidance to US$9.90–US$10.30 per diluted share. The combination of stronger quarterly earnings per share, higher operating margin and an uplift in full-year guidance highlights management’s confidence in the company’s current operating performance. Next, we’ll examine how stronger-than-expected earnings and...

TXNM Energy stock has delivered a 44.0% gain over the past three years, yet the current valuation checks lean expensive rather than cheap. With a low overall value score and an overvalued read on market multiples, investors are weighing whether the recent share price level still lines up with the company’s fundamentals. TXNM Energy’s 44.0% return over three years points to solid shareholder gains that may already reflect a lot of positive expectations in the price. The extended $11.5b merger...

Anika Therapeutics stock jumped about 12% to US$18.07 as investors rushed to price in a sharp swing back into the black. The move reflects a clear emotional relief trade after a long stretch of red ink. The headline is simple. Q2 delivered US$32.61m in revenue and US$3.31m in net income from ongoing operations, with basic earnings per share of US$0.25. The market is cheering that profitability. The real question for investors is whether this is the start of a stronger margin story or just a...